Key statistics
52-week range
Open | 1,949.00 |
---|---|
High | 1,960.35 |
Low | 1,921.05 |
Bid | 1,926.70 |
Offer | 1,926.70 |
Previous close | 1,945.00 |
Average volume | 2.10m |
---|---|
Shares outstanding | 2.40bn |
Free float | 1.06bn |
P/E (TTM) | 44.98 |
Market cap | 4.45tn INR |
EPS (TTM) | 43.32 INR |
Annual div (ADY) | 13.50 INR |
---|---|
Annual div yield (ADY) | 0.69% |
Div ex-date | Jul 12 2024 |
Div pay-date | Aug 16 2024 |
Data delayed at least 15 minutes, as of Sep 30 2024 11:28 BST.
More ▼
- Sun Pharma Presents New Clinical Efficacy and Safety Data in Severe Dermatological Conditions at the 2024 European Academy of Dermatology and Venereology (EADV) Congress
- U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
- U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata